Center For Scientific Review; Notice of Closed Meetings, 19208-19209 [2016-07546]
Download as PDF
<![CDATA[
19208
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
study (OS) comprised of women
ineligible or unwilling to participate in
the CT, to evaluate risk factors for
chronic diseases by following this large
cohort of women and relating
subsequent disease development to
baseline assessments of historical,
physical, and physiologic
characteristics. The WHI provides new
information on health and risk of
disease among older post-menopausal
women to inform development of
approaches to disease prevention. The
specific objectives of the OS are to
provide reliable estimates of the extent
to which known risk factors predict
heart disease, cancers and fractures;
identify new risk factors for these and
other diseases in women; compare risk
factors, presence of disease at the start
of the study, and new occurrences of
disease during the WHI in all study
components; and create a future
resource to identify biological indicators
of disease, especially substances and
factors found in the blood. Continued
follow-up of medical outcome
occurrences will enhance achievement
of the WHI original goals and increase
the range of scientific issues that can be
examined. Specific biomarkers will be
assessed based on current and future
hypotheses related to clinical endpoints.
The WHI study/protocol allows for
analysis and presentation of results in
aggregate form only, thus all data
including biological samples are void of
personal identifiers.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
10,796.
A.12–1—ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Form
Form
Form
Form
Form
Number of
respondents
Type of respondent
Number of
responses per
respondent
Average
burden per
response
(In hours)
Total annual
burden hours
33 Medical History Update ..................
151 Activities of Daily Life ...................
20 Personal Information Update .........
120 Initial Notification of Death ...........
120 Initial Notification of Death ...........
OS Participants ....................
OS Participants ....................
OS Participants ....................
Next of Kin ............................
Physician/Office Staff ...........
40203
40203
40203
900
15
1
1
1
1
1
7/60
6/60
3/60
5/60
5/60
4690
4020
2010
75
1
Total .......................................................
...............................................
41,118
41,118
........................
10,796
Dated: March 23, 2016.
Valery Gheen,
NHLBI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2016–07487 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Meeting
Notice is hereby given of a meeting of
the Big Data to Knowledge MultiCouncil Working Group.
The teleconference meeting will be
open to the public as indicated below.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Working Group: Big Data to
Knowledge Multi-Council Working
Group.
Date: April 25, 2016.
Open: 11:00 a.m. to 12:30 p.m.
Agenda: April 2016 MCWG Open
Session, Discussion will review current
Big Data to Knowledge (BD2K) activities
and newly proposed BD2K initiatives.
Place: Teleconference, Join WebEx
meeting, Telephone Number: 1–877–
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
668–4493, Meeting Number: 622 421
867.
Note: This portion of the meeting is
open to the public but is being held by
teleconference only. No physical
meeting location is provided for any
interested individuals to listen to
committee discussions. Any individual
interested in listening to the meeting
discussions must call: 1–877–668–4493
and use Meeting number: 622 421 867
for access to the meeting. Participants
can also join in on the viewing the
presentation by clicking the following
link Join WebEx meeting.
Any interested person may file
written comments with the working
group or submit questions by sending an
email to the Contact Person listed on
this notice. The email should include
the name, addresses, telephone number
and when applicable, the business or
professional affiliation of the interested
person.
Closed: 12:30 p.m.–3:30 p.m.
Agenda: April 2016 MCWG Closed
Session, Discussion will focus on
review of proposed Funding Plans for
BD2K Funding Opportunity
Announcements.
Place: Teleconference.
Contact Person: Tonya Scott,
Scientific Program Analyst, Office of the
Associate Director of Data Science
(ADDS), National Institutes of Health, 1
Center Drive, Room 325, Bethesda, MD
20892, email: tonya.scott@nih.gov,
Telephone: 301–402–9817.
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
Additional information on data
science is available at: https://
datascience.nih.gov/index and
additional information on the Working
Group is available at: https://
datascience.nih.gov/bd2k/about/org/
MCWG.
Dated: March 29, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–07542 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\04APN1.SGM
04APN1
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, AIDS and
Related Research Member Conflicts:
Opportunistic Infections.
Date: April 12, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA RM13–
006: Pioneer Awards.
Date: April 25–27, 2016.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: James W. Mack, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4154,
MSC 7806, Bethesda, MD 20892, (301) 435–
2037, mackj2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 29, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–07546 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project II.
Date: June 7–8, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Robert Bird, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W110, Bethesda, MD 20892–9750, 240–276–
6344, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project IV.
Date: June 8, 2016.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W122, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Shakeel Ahmad, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division Of Extramural
Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W122,
Bethesda, MD 20892–9750, 240–276–6349,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
J—Career Development.
Date: June 8–9, 2016.
Time: 6:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Tushar B. Deb, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W624, Rockville, MD 20850, 240–276–6132,
tushar.deb@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SPORE
Review II.
Date: June 15–16, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Wlodek Lopaczynski,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W608, Rockville, MD 20850, 240–
276–6458, lopacw@mail.nih.gov.
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
19209
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 28, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–07481 Filed 4–1–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID SBIR Phase II
Clinical Trial Implementation Cooperative
Agreement (U44).
Date: May 4, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
NIAID, Team Room 3G61, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: B. Duane Price, Ph.D.,
Scientific Review Officer Scientific Review
Program, Division of Extramural Activities,
Rm. 3G50, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9834,
Bethesda, MD 20892–9834, 240–669–5074,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Application (P01).
Date: May 9, 2016.
Time: 8:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Pages 19208-19209]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07546]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 19209]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, AIDS and Related Research Member Conflicts: Opportunistic
Infections.
Date: April 12, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Robert Freund, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435-
1050, freundr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA RM13-006: Pioneer Awards.
Date: April 25-27, 2016.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: James W. Mack, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4154, MSC 7806, Bethesda, MD 20892, (301) 435-
2037, mackj2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 29, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-07546 Filed 4-1-16; 8:45 am]
BILLING CODE 4140-01-P
